Back to trial details

Intake questionnaire

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

Applying to Sahni Rheumatology & Therapy · West Long Branch, New Jersey

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 75 years old?
2. Have you been diagnosed with Lupus Nephritis?
3. Are you able to travel to West Long Branch for study visits?